AstraZeneca Signs Memorandum With Gamaleya Centre, RDIF And R-Pharm

Eurasia Review

Published

After a series of negotiations, British drugmaker AstraZeneca has finally signed a Memorandum of Intent with Russia's Gamaleya Institute, which developed Sputnik V, Russia's RDIF sovereign wealth fund, and Russian drugmaker R-Pharm.

The memorandum allows for joint efforts to find sustainable solution to the coronavirus...

Full Article